Loading clinical trials...
Loading clinical trials...
Cryoablation or tumor freezing is a percutaneous, office-based procedure that is emerging as a minimally invasive, cost-effective alternative to surgery that is currently being evaluated in clinical trials for the management of for early-stage invasive breast cancer. The investigator will also evaluate the potential of cryoablation as a minimally invasive alternative to surgery for small areas of DCIS by examining its ability to achieve complete ablation of DCIS within the targeted cryoablation zone of necrosis.
Age
18 - No limit years
Sex
FEMALE
Healthy Volunteers
No
Office of Dennis R. Holmes, M.D., F.A.C.S.
Glendale, California, United States
Start Date
November 1, 2021
Primary Completion Date
November 1, 2026
Completion Date
November 1, 2026
Last Updated
March 3, 2023
30
ESTIMATED participants
Cryoablation
PROCEDURE
Lead Sponsor
Glendale Adventist Medical Center d/b/a Adventist Health Glendale
Collaborators
NCT06538389
NCT06902311
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions